PhRMA Says HRSA Misinterprets 340B Orphan Drug Exclusion

by Admin | February 26, 2015 5:05 pm

February 26, 2015—The Department of Health and Human Services Health Resources and Services Administration cannot second-guess Congress and rewrite the 340B orphan drug exclusion “to make the statute correspond with the agency’s policy preference,” brand-name drugmakers said yesterday in a court filing. 

---

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Source URL: https://340binformed.org/2015/02/phrma-says-hrsa-misinterprets-340b-orphan-drug-exclusion/

---